BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33480040)

  • 1. Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.
    Han B; Zhang YY; Ye ZQ; Xiao Y; Rasouli J; Wu WC; Ye SM; Guo XY; Zhu L; Rostami A; Wang LB; Zhang Y; Li X
    Immunology; 2021 Jun; 163(2):185-200. PubMed ID: 33480040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYSLTR1 antagonist inhibits Th17 cell differentiation by regulating the NF-κB signaling for the treatment of psoriasis.
    Zhao J; Chen Y; Li L; Yin H; Song S; Wang Y; Feng X; Fan X; Gao C; Gao L; Zhan Y; Zhao M; Li X; Lu Q
    Int J Biol Sci; 2024; 20(6):2168-2186. PubMed ID: 38617532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes induce the migration of Th17 cells.
    Lee W; Su Kim H; Lee GR
    Immunol Cell Biol; 2015; 93(5):472-9. PubMed ID: 25512344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
    Marschallinger J; Altendorfer B; Rockenstein E; Holztrattner M; Garnweidner-Raith J; Pillichshammer N; Leister I; Hutter-Paier B; Strempfl K; Unger MS; Chishty M; Felder T; Johnson M; Attems J; Masliah E; Aigner L
    Neurotherapeutics; 2020 Jul; 17(3):1061-1074. PubMed ID: 32072462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2).
    Li Z; Wang J; Ma Y
    Bioengineered; 2021 Dec; 12(1):8476-8484. PubMed ID: 34565285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma.
    Trinh HKT; Suh DH; Nguyen TVT; Choi Y; Park HS; Shin YS
    Prostaglandins Leukot Essent Fatty Acids; 2019 Feb; 141():17-23. PubMed ID: 30661601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's Disease.
    Wallin J; Svenningsson P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
    Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
    Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis
    Zhu H; Li G; Yin J; Zhang H; Da Y; Li L
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):594-602. PubMed ID: 35638564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children.
    Zhao M; Li H; Li H
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4847-4853. PubMed ID: 33837837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
    Duc D; Vigne S; Bernier-Latmani J; Yersin Y; Ruiz F; Gaïa N; Leo S; Lazarevic V; Schrenzel J; Petrova TV; Pot C
    Cell Rep; 2019 Oct; 29(2):378-390.e4. PubMed ID: 31597098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.
    Quinn JL; Kumar G; Agasing A; Ko RM; Axtell RC
    Front Immunol; 2018; 9():382. PubMed ID: 29535739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
    Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
    J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.
    Al-Kuraishy HM; Al-Gareeb AI; Almulaiky YQ; Cruz-Martins N; El-Saber Batiha G
    Eur J Pharmacol; 2021 Aug; 904():174196. PubMed ID: 34004207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.